Company Profile
Cardiff Oncology Stock Price, News & Analysis
- Ticker:
- CRDF
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Cardiff Oncology is followed within the oncology universe where readouts and regulatory timing often dominate the stock.
Stock performance
1.25 USD (-3.85%)
Close
Last updated: June 23, 2026 at 00:00
85.46M USD
Market cap
Why the stock is moving
CRDF is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Cardiff Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Cardiff Oncology is followed within the oncology universe where readouts and regulatory timing often dominate the stock.
Business Model Characteristics
Cardiff Oncology follows a pipeline-and-commercial model where investors track trial execution, launch cadence, and the pace at which oncology data can be turned into durable product value.
Position Within the Biotechnology Landscape
Compared with larger diversified peers, Cardiff Oncology sits in a high-catalyst corner of the biotech landscape, where oncology updates can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Cardiff Oncology (CRDF)?
Cardiff Oncology (CRDF) most recently closed at 1.25 USD, a -3.85% move versus the previous session.
What is the market cap of Cardiff Oncology (CRDF)?
Cardiff Oncology currently has a market capitalization of 85.46M USD on BioPharmSignal.
What does Cardiff Oncology do?
Cardiff Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
On which exchange is CRDF stock listed?
Cardiff Oncology (CRDF) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Cardiff Oncology is followed within the oncology universe where readouts and regulatory timing often dominate the stock., Biotechnology.
What is Cardiff?
Cardiff Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
Which conditions is Cardiff Oncology targeting with Cardiff?
Cardiff Oncology is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
What is Oncology?
Cardiff Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.